|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Novel Drug Therapies in the Treatment of Dermatophytosis |
| Authors Name: | Fida P , Dr. Sreejith K , Thabshira M , PP Shahda , Simakh AP |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_215932
|
| Published Paper Id: | IJNRD2403451 |
| Published In: | Volume 9 Issue 3, March-2024 |
| DOI: | |
| Abstract: | Dermatophytes are a major cause of fungal infections worldwide, and they are quite common in developing countries. Recent studies show that these infections have been increasing notably in India, particularly in the last few years. The rise in recurrent or chronic cases has made it clear that we need novel drug therapies for dermatophytosis treatment. Also, there is a worrying increase in resistance to the usual oral and topical antifungal medicines. Novel formulations or newer derivatives of existing drug classes and few newer drug classes are being developed by researchers for the treatment of chronic or extensive dermatophytosis. Newer topical drugs include efinaconazole, tavaborole, ciclopirox HPCH lacquer, econazole and luliconazole. Additional forms of local therapies including photodynamic therapy and laser irradiation are also recommended for dermatophytosis treatment. |
| Keywords: | Dermatophytosis, Tinea, Novel drug, Fosravuconazole, Voriconazole, SUBA Itraconazole, Efinaconazole, Tavaborole, Sertaconazole, Laser therapy |
| Cite Article: | "Novel Drug Therapies in the Treatment of Dermatophytosis", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 3, page no.e410-e414, March-2024, Available :http://www.ijnrd.org/papers/IJNRD2403451.pdf |
| Downloads: | 00027 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2403451 Registration ID: 215932 Published In: Volume 9 Issue 3, March-2024 DOI (Digital Object Identifier): Page No: e410-e414 Country: Kozhikode, Kerala, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2403451 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2403451 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn